Target intelligence / Profile preview

B-cell receptor specific for Neisseria meningitidis capsular polysaccharide serogroup C (BCR-MenC) (BCR-MenC)

Target
BCR-MenC
Molecular classification
Receptor, Other
01

Overview

The B-cell receptor (BCR) specific for Neisseria meningitidis capsular polysaccharide serogroup C is a membrane-bound immunoglobulin complex located on the surface of specific B lymphocytes [1]. Its primary biological function is the high-affinity recognition of the α(2→9)-linked sialic acid homopolymer that constitutes the MenC capsule [2]. Upon binding to its cognate antigen, the BCR triggers intracellular signaling pathways that lead to B-cell activation, proliferation, and differentiation into memory B cells and plasma cells [2]. This receptor is the fundamental target for meningococcal serogroup C conjugate vaccines, which are designed to overcome the T-cell independent nature of pure polysaccharides by linking them to carrier proteins [3]. The interaction between the vaccine antigen and the BCR is essential for inducing a robust, long-lasting immune response characterized by high titers of serum bactericidal antibodies (SBA) [1, 3]. These antibodies provide protection by facilitating complement-mediated lysis of the bacteria, thereby preventing invasive diseases such as meningitis and septicemia [4]. The BCR's ability to internalize the conjugated antigen for processing and presentation to T-helper cells is a key mechanism in the success of these vaccines [2]. Consequently, this receptor serves as the critical interface between the vaccine and the adaptive immune system to ensure long-term protection against Neisseria meningitidis [1]. Sources: [1] WHO (https://www.who.int/news-room/fact-sheets/detail/meningococcal-meningitis); [2] Pollard AJ, et al. Vaccine. 2000; [3] CDC (https://www.cdc.gov/vaccines/vpd/mening/hcp/index.html); [4] Borrow R, et al. Infect Immun. 2001.

Other names
Meningococcal serogroup C-specific B-cell receptorMenC-specific B-cell receptorAnti-MenC BCR
02

Mechanism of action

Antigen binding to the B-cell receptor (BCR) triggers B-cell activation and, in the case of conjugate vaccines, receptor-mediated endocytosis for T-cell dependent immune responses, leading to the production of protective IgG antibodies and memory B cells [2, 3].

03

Biological functions

Immune responseOther
04

Disease associations

Infection
05

Safety considerations

Hypersensitivity reactionsInjection site reactionsAnaphylaxisPotential for immune interference in multi-component vaccines
06

Interacting drugs

Meningococcal Group C Conjugate Vaccine

6 more in the full profile.

07

Biomarkers

Serum bactericidal antibody (SBA) titerMenC-specific IgG concentrationMenC-specific memory B-cell frequency

Beyond the preview

Go deeper on B-cell receptor specific for Neisseria meningitidis capsular polysaccharide serogroup C (BCR-MenC) (BCR-MenC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on B-cell receptor specific for Neisseria meningitidis capsular polysaccharide serogroup C (BCR-MenC) (BCR-MenC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call